Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Aim This is the third version of the guideline of the World Federation of Societies of
Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

The efficacy of (cognitive) behavioural ((C) BT) and pharmacological therapy was
investigated using meta-analytic techniques. After a comprehensive review of the literature …

Background: Placebo-controlled trials showed that both benzodiazepines (BDZ) and
antidepressant drugs (AD) are effective in treating anxiety disorders. However, in the last …

Bakker A, van Balkom AJLM, Spinhoven P. SSRIs vs. TCAs in the treatment of panic
disorder: a meta‐analysis. Acta Psychiatr Scand 2002: 106: 163–167.© Blackwell …

Alprazolam is a benzodiazepine derivative that is currently used in the treatment of
generalized anxiety, panic attacks with or without agoraphobia, and depression. Alprazolam …

Background Panic disorder is characterised by repeated, unexpected panic attacks, which
represent a discrete period of fear or anxiety that has a rapid onset, reaches a peak within …

Moderní trendy v léčbě. Úzkostné poruchy představují nejčastější psychické poruchy, které
postihují velkou část populace. Setkávají se s nimi nejen psychiatři a psychoterapeuti, ale i …